Evidence map›Paper›PMID 36636491›Full record

ArticleMicrobial cell (Graz, Austria)2023

Cellular cholesterol licenses

Edna Ondari, Ashley Wilkins, Brian Latimer, Ana-Maria Dragoi, Stanimir S Ivanov

Open access · goldAbstract read
In one paragraph

Article in Microbial cell (Graz, Austria), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Molecular biology of the cell · 2025
    Article
  4. Journal of bacteriology · 2024
    Review
  5. Article
  6. Article
  7. Characterization ofFrontiers in cellular and infection microbiology · 2024
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Edna OndariDepartment of Microbiology and Immunology, Louisiana State University Health - Shreveport, Shreveport, LA 71130.
Ashley WilkinsDepartment of Microbiology and Immunology, Louisiana State University Health - Shreveport, Shreveport, LA 71130.
Brian LatimerInnovative North Louisiana Experimental Therapeutics program (INLET), Feist-Weiller Cancer Center, Louisiana State University Health - Shreveport, Shreveport, LA 71130.
Ana-Maria DragoiDepartment of Molecular and Cellular Physiology, Louisiana State University Health - Shreveport, Shreveport, LA 71130.
Stanimir S IvanovDepartment of Microbiology and Immunology, Louisiana State University Health - Shreveport, Shreveport, LA 71130.
Louisiana State University Health Sciences Center Shreveport · USLouisiana State University in Shreveport · US

Funding

Regulation of Legionella pneumophila pathogenesis by the central eukaryotic metabolic checkpoint kinase Mechanistic Target of Rapamycin (MTOR)R01AI143839 · NIAID · LOUISIANA STATE UNIV HSC SHREVEPORT · PI IVANOV, STANIMIR STEFANOV · 2019 to 2023
$1.8M
NIAID NIH HHS R01 AI143839
6 · The paper itself

Abstract

Host membranes are inherently critical for niche homeostasis of vacuolar pathogens. Thus, intracellular bacteria frequently encode the capacity to regulate host lipogenesis as well as to modulate the lipid composition of host membranes. One membrane component that is often subverted by vacuolar bacteria is cholesterol - an abundant lipid that mammalian cells produce

Indexed as

cholesterolintracellular replicationLegionella pneumophilamacrophageniche homeostasis

Identifiers

PMID36636491
PMCPMC9806796
OpenAlexW4313388788

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.